Morgan Stanley Believes Bristol-Myers Squibb Co. Could Move Significantly Over Next Several Months
October 02, 2014 at 10:15 AM EDT
In a report published Thursday, Morgan Stanley analyst David Risinger reiterated an Overweight rating and $60.00 price target on ...